Form 4 for NGVT Ingevity Corp
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001493152-21-027899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-10 | 2021-11-08 | NGVT | Smith Michael P. | EVP, Pres Perf Chemicals | M - OptEx | $42.88 | +7,878 | 30.4K | +35% | +$337.8K |
| DM | 2021-11-10 | 2021-11-08 | NGVT | Smith Michael P. | EVP, Pres Perf Chemicals | S - Sale+OE | $80.81 | -7,878 | 22.5K | -26% | -$636.6K |
| DM | 2021-11-10 | 2021-11-08 | NGVT | Smith Michael P. | EVP, Pres Perf Chemicals | M - OptEx | $0.00 | -7,878 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-08 | M | A | 4,257 | $34.18 | 26,766 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-08 | S | D | 4,257 | $80.81 | 26,130 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-08 | M | A | 3,621 | $53.11 | 30,387 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-08 | S | D | 3,621 | $80.81 | 22,509 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right-to-buy) | 2021-11-08 | M | D | 4,257 | $0.00 | 0 | D | $34.18 · 2019-02-27 to 2026-05-27 | 4,257 Common Stock | |
| 6 | Derivative | Employee Stock Option (right-to-buy) | 2021-11-08 | M | D | 3,621 | $0.00 | 0 | D | $53.11 · 2020-02-27 to 2027-02-27 | 3,621 Common Stock |